Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04787289
Title A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications

ovary epithelial cancer

fallopian tube carcinoma

peritoneal carcinoma

Therapies

Bevacizumab

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.